ArticleOncogenesis2019

LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells.

Shuang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.